Canal Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.8M Buy
24,312
+1,055
+5% +$361K 1.08% 26
2026
Q1
$8.18M Buy
23,257
+292
+1% +$104K 1.11% 27
2025
Q4
$7.52M Buy
22,965
+613
+3% +$194K 1.07% 34
2025
Q3
$6.31M Buy
22,352
+724
+3% +$210K 0.95% 39
2025
Q2
$6.04M Buy
21,628
+1,359
+7% +$385K 0.95% 36
2025
Q1
$6.31M Buy
+20,269
New +$5.99M 1.06% 33

Other funds holding AMGN

Canal Capital Management's AMGN Position: Q2 2026 in Review

Canal Capital Management increased its Amgen (AMGN) stake by 4.5% in Q2 2026, buying an estimated $361K and bringing the position to 24,312 shares worth $8.8M. The position accounts for 1.08% of the portfolio, ranked #26.

Canal Capital Management first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Canal Capital Management held 24,312 shares of Amgen worth $8.8M as of Q2 2026.
  • Canal Capital Management bought 1,055 Amgen shares in Q2 2026, an estimated $361K.
  • Amgen made up 1.08% of Canal Capital Management's portfolio in Q2 2026, its #26 holding.
  • Canal Capital Management first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Canal Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.